secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zai Lab Ltd (ZLAB)
CIK:        0001704292
Form:       8-K
Filed at:   2022-06-22T23:59:59+00:00
Accession:  0001193125-22-178758
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zai Lab shareholders approve 2022 Equity Plan and amended Articles for HK dual-primary listing
--------------------------------------------------------------------------------

- Shareholders approved 2022 Equity Incentive Plan (97,908,743 shares) conditioned on HKEX dual-primary listing becoming effective.
- Sixth Amended and Restated Memorandum and Articles of Association approved to reflect HK listing requirements and March 2022 share subdivision.
- All twelve director nominees re-elected, including CEO Samantha Du and chairs; advisory vote on exec compensation set for annual frequency.
- Ratification of KPMG LLP as independent auditor for FY2022; share issue mandate of up to 20% of issued shares approved.
- Plan replaces 2017 and 2015 plans; no new grants under old plans after HK dual-primary listing effective date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704292/000119312522178758/0001193125-22-178758-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704292/000119312522178758/d362463d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-178758

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer